Zonisamide as a treatment for partial epileptic seizures: A systematic review

Joanna H. Cox, Stefano Seri, Andrea E. Cavanna*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Although the majority of people with epilepsy have a good prognosis and their seizures can be well controlled with pharmacotherapy, up to one-third of patients can develop drug-resistant epilepsy, especially those patients with partial seizures. This unmet need has driven considerable efforts over the last few decades aimed at developing and testing newer antiepileptic agents to improve seizure control. One of the most promising antiepileptic drugs of the new generation is zonisamide, a benzisoxazole derivative chemically unrelated to other anticonvulsant agents. In this article, the authors present the results of a systematic literature review summarizing the current evidence on the efficacy and tolerability of zonisamide for the treatment of partial seizures. Of particular interest within this updated review are the recent data on the use of zonisamide as monotherapy, as they might open new therapeutic avenues. © 2014 Springer Healthcare.

Original languageEnglish
Pages (from-to)276-288
Number of pages13
JournalAdvances in Therapy
Volume31
Issue number3
Early online date13 Feb 2014
DOIs
Publication statusPublished - 1 Mar 2014

Fingerprint

zonisamide
Epilepsy
Seizures
Anticonvulsants
Therapeutics
Delivery of Health Care
Drug Therapy

Keywords

  • efficacy
  • epilepsy
  • neurology
  • partial seizures
  • tolerability
  • zonisamide

Cite this

Cox, Joanna H. ; Seri, Stefano ; Cavanna, Andrea E. / Zonisamide as a treatment for partial epileptic seizures : A systematic review. In: Advances in Therapy. 2014 ; Vol. 31, No. 3. pp. 276-288.
@article{57f9cc99a5ad40289f4131f7d6e0ad8b,
title = "Zonisamide as a treatment for partial epileptic seizures: A systematic review",
abstract = "Although the majority of people with epilepsy have a good prognosis and their seizures can be well controlled with pharmacotherapy, up to one-third of patients can develop drug-resistant epilepsy, especially those patients with partial seizures. This unmet need has driven considerable efforts over the last few decades aimed at developing and testing newer antiepileptic agents to improve seizure control. One of the most promising antiepileptic drugs of the new generation is zonisamide, a benzisoxazole derivative chemically unrelated to other anticonvulsant agents. In this article, the authors present the results of a systematic literature review summarizing the current evidence on the efficacy and tolerability of zonisamide for the treatment of partial seizures. Of particular interest within this updated review are the recent data on the use of zonisamide as monotherapy, as they might open new therapeutic avenues. {\circledC} 2014 Springer Healthcare.",
keywords = "efficacy, epilepsy, neurology, partial seizures, tolerability, zonisamide",
author = "Cox, {Joanna H.} and Stefano Seri and Cavanna, {Andrea E.}",
year = "2014",
month = "3",
day = "1",
doi = "10.1007/s12325-014-0104-1",
language = "English",
volume = "31",
pages = "276--288",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Health Communications Inc.",
number = "3",

}

Zonisamide as a treatment for partial epileptic seizures : A systematic review. / Cox, Joanna H.; Seri, Stefano; Cavanna, Andrea E.

In: Advances in Therapy, Vol. 31, No. 3, 01.03.2014, p. 276-288.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Zonisamide as a treatment for partial epileptic seizures

T2 - A systematic review

AU - Cox, Joanna H.

AU - Seri, Stefano

AU - Cavanna, Andrea E.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Although the majority of people with epilepsy have a good prognosis and their seizures can be well controlled with pharmacotherapy, up to one-third of patients can develop drug-resistant epilepsy, especially those patients with partial seizures. This unmet need has driven considerable efforts over the last few decades aimed at developing and testing newer antiepileptic agents to improve seizure control. One of the most promising antiepileptic drugs of the new generation is zonisamide, a benzisoxazole derivative chemically unrelated to other anticonvulsant agents. In this article, the authors present the results of a systematic literature review summarizing the current evidence on the efficacy and tolerability of zonisamide for the treatment of partial seizures. Of particular interest within this updated review are the recent data on the use of zonisamide as monotherapy, as they might open new therapeutic avenues. © 2014 Springer Healthcare.

AB - Although the majority of people with epilepsy have a good prognosis and their seizures can be well controlled with pharmacotherapy, up to one-third of patients can develop drug-resistant epilepsy, especially those patients with partial seizures. This unmet need has driven considerable efforts over the last few decades aimed at developing and testing newer antiepileptic agents to improve seizure control. One of the most promising antiepileptic drugs of the new generation is zonisamide, a benzisoxazole derivative chemically unrelated to other anticonvulsant agents. In this article, the authors present the results of a systematic literature review summarizing the current evidence on the efficacy and tolerability of zonisamide for the treatment of partial seizures. Of particular interest within this updated review are the recent data on the use of zonisamide as monotherapy, as they might open new therapeutic avenues. © 2014 Springer Healthcare.

KW - efficacy

KW - epilepsy

KW - neurology

KW - partial seizures

KW - tolerability

KW - zonisamide

UR - http://www.scopus.com/inward/record.url?scp=84898924244&partnerID=8YFLogxK

U2 - 10.1007/s12325-014-0104-1

DO - 10.1007/s12325-014-0104-1

M3 - Article

C2 - 24522856

VL - 31

SP - 276

EP - 288

JO - Advances in Therapy

JF - Advances in Therapy

SN - 0741-238X

IS - 3

ER -